BlackRock, Inc. 13D and 13G filings for Abbott Laboratories:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Abbott Laboratories ABT |
BLACKROCK INC BLK |
134,061,311 7.700% |
-5,464,905 (-3.92%) |
Filing |
| 2023-02-06 4:35 pm Purchase |
2022-12-31 | 13G | Abbott Laboratories ABT |
BLACKROCK INC BLK |
139,526,216 8.000% |
2,370,614 (+1.73%) |
Filing |
| 2022-01-31 5:49 pm Purchase |
2021-12-31 | 13G | Abbott Laboratories ABT |
BLACKROCK INC BLK |
137,155,602 7.800% |
3,728,792 (+2.79%) |
Filing |
| 2021-01-28 5:56 pm Purchase |
2020-12-31 | 13G | Abbott Laboratories ABT |
BLACKROCK INC BLK |
133,426,810 7.500% |
8,698,208 (+6.97%) |
Filing |